4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000176
Chairperson & CEO sold 9,500 shares at an average $600.09 ($5,700,856)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-30 | Sale : show line 2 in the form 10b5-1 | −119 | $594.92 | $70,795 | 333,824 | I |
| 2026-10-30 | Sale : show line 3 in the form 10b5-1 | −728 | $596.01 | $433,893 | 333,096 | I |
| 2026-10-30 | Sale : show line 4 in the form 10b5-1 | −393 | $596.84 | $234,557 | 332,703 | I |
| 2026-10-30 | Sale : show line 5 in the form 10b5-1 | −1,496 | $598.04 | $894,664 | 331,207 | I |
| 2026-10-30 | Sale : show line 6 in the form 10b5-1 | −884 | $598.94 | $529,465 | 330,323 | I |
| 2026-10-30 | Sale : show line 7 in the form 10b5-1 | −1,200 | $600.25 | $720,302 | 329,123 | I |
| 2026-10-30 | Sale : show line 8 in the form 10b5-1 | −1,742 | $600.96 | $1,046,865 | 327,381 | I |
| Open-market sales · 9,500 sh · avg $600.09 · $5,700,856 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option | −9,500 | 119,410 | I |
Loading xslF345X06/primarydocument.xml…